Olaratumab in Soft Tissue Sarcoma – Current Status and Future Perspectives

European Journal of Cancer - United Kingdom
doi 10.1016/j.ejca.2017.12.026
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Developments in the Management of Advanced Soft-Tissue Sarcoma &Ndash; Olaratumab in Context

OncoTargets and Therapy
OncologyPharmacology
2018English

Olaratumab and Doxorubicin for the Treatment of Metastatic Soft Tissue Sarcoma: A Retrospective Case Series

Precision and Future Medicine
2019English

Congenital Hyperinsulinism: Current Status and Future Perspectives

Annals of Pediatric Endocrinology and Metabolism
Child HealthEndocrinologyPerinatologyPediatricsMetabolismDiabetes
2014English

Energy Medicine: Current Status and Future Perspectives

Global Advances In Health and Medicine
Medicine
2019English

Immunotherapy in Soft-Tissue Sarcoma

Current Oncology
Oncology
2020English

Gastric Carcinoma in China: Current Status and Future Perspectives (Review)

Oncology Letters
Cancer ResearchOncology
2010English

Three-Dimensional Printing in Medicine: Current Status and Future Perspectives

Cyprus Journal of Medical Sciences
2019English

Biomarkers of Parkinson's Disease: Current Status and Future Perspectives

Drug Discovery Today
Drug DiscoveryPharmacology
2013English

Retroperitoneal Soft Tissue Sarcoma

BMC Cancer
Cancer ResearchOncologyGenetics
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy